Microbix Biosystems Inc. (TSE:MBX) Insider Microbix Biosystems Inc. Purchases 600,359 Shares

Microbix Biosystems Inc. (TSE:MBX) insider Microbix Biosystems Inc. acquired 600,359 shares of the company’s stock in a transaction on Friday, August 30th. The stock was acquired at an average price of C$0.34 per share, with a total value of C$204,122.06.

Microbix Biosystems Price Performance

The company’s 50 day simple moving average is C$0.34 and its 200 day simple moving average is C$0.35. Microbix Biosystems Inc. has a twelve month low of C$0.23 and a twelve month high of C$0.45. The company has a market capitalization of C$51.26 million, a P/E ratio of 9.25 and a beta of 0.36. The company has a debt-to-equity ratio of 22.68, a quick ratio of 5.57 and a current ratio of 6.62.

About Microbix Biosystems

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.